Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zambia PCPI: SP Chemoprevention Efficacy
NCT06166498Phase 3Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Jul 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sulfadoxine + pyrimethamine in malaria, sponsored by London School of Hygiene & Tropical Medicine. Started Jul 2024; status: completed.
02
Drugs
sulfadoxine + pyrimethamine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT06166498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06166498.